Generate a tailored SOP for Dr. Carlos Fernandez Hernando. Improve your application with a focused, well-structured draft.
Carlos studied Biochemistry and Molecular Biology at Universidad Autonoma Madrid, obtaining his PhD in 2004. He completed postdoctoral training at Yale University from 2005 to 2009. Currently, he serves as the Antony N. Brady Professor of Comparative Medicine and Professor of Pathology at Yale School of Medicine, where he also directs the Vascular Biology & Therapeutics Program. His research mainly focuses on investigating the role of microRNAs in lipid metabolism and cholesterol regulation. He has shown that certain microRNAs, particularly miR-33, significantly influence cholesterol homeostasis and have therapeutic potential in cardiovascular disease by regulating expression of key genes involved in lipid transport. Carlos is dedicated to uncovering the intricate molecular mechanisms underlying lipid metabolism, aiming to identify novel genes and pathways that could be targeted for developing strategies to manage cholesterol-related disorders. Collaborating with various researchers, he has contributed to significant advancements in the understanding of atherosclerosis and related vascular diseases.
GRE is optional for PhD applicants. TOEFL speaking scores below 26 or IELTS speaking below 7.5 may require summer English training.